electroCore, Inc. Sale of Stock, Consideration Received on Transaction
electroCore, Inc. (ECOR) reported Sale of Stock, Consideration Received on Transaction of $6.90 million for the 1-month period ending 2021-01-31, per its 10-K filed 2022-03-10.
Discontinued › Notes › Equity
us-gaap:SaleOfStockConsiderationReceivedOnTransaction · last filed 2022-03-10
- 2021-01-31: Sale of Stock, Consideration Received on Transaction 1 month $6.90M.
| Period end | Sale of Stock, Consideration Received on Transaction 1 month |
|---|---|
| 2021-01-31 | $6.90M 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |